What's New
Front Page
Former Biochemistry Professor Shares First-Hand Experience Living with nfvPPA
Joanne T. Douglas, PhD, a former biochemistry professor at the University of Alabama at Birmingham, shared her…
U.S. News & World Report Explores Antipsychotic Drug Use in Dementia Care
A recent article in US News & World Report explores the use of antipsychotic drugs to treat dementia…
Tips and Advice: Managing Communication Difficulties
As FTD progressively affects areas of the brain that control reading, writing, speaking, and understanding language, communicating…
AFTD Webinar: The Promise of FTD Research Trials — What Should I Know About Current Drug Studies?
The science of FTD is quickly evolving. While several years ago, there were no experimental treatments for…
AFTD Senior Director of Scientific Initiatives Talks About FTD Research on Remember Me Podcast
AFTD Senior Director of Scientific Initiatives Penny Dacks, PhD, discussed the different types of ongoing FTD research…
#FromHopeToAction: AFTD’s 2022 Annual Report
AFTD’s 2022 Annual Report documents progress made bringing hope to action in each area of our mission…
World Health Organization Publishes “Blueprint” for Global Dementia Research
The World Health Organization (WHO) has published a blueprint for dementia research to guide stakeholders around the…
L.A. Rams Coach Zac Robinson Shows Support for AFTD’s Mission with Special Cleats
Zac Robinson, quarterback coach and pass game coordinator for the Los Angeles Rams, will don special AFTD-themed…
Guest Feature: Grace for Yourself
The FTD journey is an emotionally taxing experience, with feelings of guilt, anger, resentment, and frustration accompanying…
AFTD News: Fall 2022, Vol. 19, Issue 3
In this issue: From Hope to Action: AFTD Commits to Bold 2022-2025 Strategic Plan; AFTD Updates Several…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)